These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28846941)

  • 41. Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST).
    Humeniuk R; Ali R; Babor TF; Farrell M; Formigoni ML; Jittiwutikarn J; de Lacerda RB; Ling W; Marsden J; Monteiro M; Nhiwatiwa S; Pal H; Poznyak V; Simon S
    Addiction; 2008 Jun; 103(6):1039-47. PubMed ID: 18373724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring Differences in Baseline Characteristics among Adults Entering Integrated Residential Treatment for Co-occurring Disorders in 2013 and 2017.
    Snyder SM; Morse SA; Bride BE
    Soc Work Public Health; 2022 Feb; 37(2):186-194. PubMed ID: 34699339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remission of psychiatric symptoms among drug misusers after drug dependence treatment.
    Gossop M; Marsden J; Stewart D
    J Nerv Ment Dis; 2006 Nov; 194(11):826-32. PubMed ID: 17102706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
    Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
    Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial validation of a computer-administered Addiction Severity Index: the ASI-MV.
    Butler SF; Budman SH; Goldman RJ; Newman FL; Beckley KE; Trottier D; Cacciola JS
    Psychol Addict Behav; 2001 Mar; 15(1):4-12. PubMed ID: 11255937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of case vignettes for Addiction Severity Index training.
    Cacciola JS; Alterman AI; Fureman I; Parikh GA; Rutherford MJ
    J Subst Abuse Treat; 1997; 14(5):439-43. PubMed ID: 9437613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New data from the Addiction Severity Index. Reliability and validity in three centers.
    McLellan AT; Luborsky L; Cacciola J; Griffith J; Evans F; Barr HL; O'Brien CP
    J Nerv Ment Dis; 1985 Jul; 173(7):412-23. PubMed ID: 4009158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health Care Processes Contributing to Suicide Risk in Veterans During and After Residential Substance Abuse Treatment.
    Riblet NB; Kenneally L; Shiner B; Watts BV
    J Dual Diagn; 2019; 15(4):217-225. PubMed ID: 31253073
    [No Abstract]   [Full Text] [Related]  

  • 51. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary medical care and reductions in addiction severity: a prospective cohort study.
    Saitz R; Horton NJ; Larson MJ; Winter M; Samet JH
    Addiction; 2005 Jan; 100(1):70-8. PubMed ID: 15598194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations.
    Reckers-Droog V; Goorden M; Kaminer Y; van Domburgh L; Brouwer W; Hakkaart-van Roijen L
    PLoS One; 2020; 15(9):e0238858. PubMed ID: 32915870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the Addiction Severity Index (ASI) and the Global Appraisal of Individual Needs (GAIN) in predicting the effectiveness of drug treatment programs for pregnant and postpartum women.
    Coleman-Cowger VH; Dennis ML; Funk RR; Godley SH; Lennox RD
    J Subst Abuse Treat; 2013 Jan; 44(1):34-41. PubMed ID: 22436533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brief screening for co-occurring disorders among women entering substance abuse treatment.
    Lincoln AK; Liebschutz JM; Chernoff M; Nguyen D; Amaro H
    Subst Abuse Treat Prev Policy; 2006 Sep; 1():26. PubMed ID: 16959041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
    Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
    Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severity of substance abuse and psychiatric problems among perinatal drug-dependent women.
    Miles DR; Kulstad JL; Haller DL
    J Psychoactive Drugs; 2002; 34(4):339-46. PubMed ID: 12562101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of two ASI-based standardized patient placement approaches.
    Camilleri AC; Cacciola JS; Jenson MR
    J Addict Dis; 2012; 31(2):118-29. PubMed ID: 22540434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using the addiction severity index to predict mental and medical health service utilization.
    Wryobeck JM; Chermack ST; Closser MH; Blow FC
    J Addict Dis; 2006; 25(4):1-14. PubMed ID: 17088221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.